European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics

J.P. Thyssen, C. Vestergaard, S. Barbarot, Marjolein de Bruin‐Weller, Thomas Bieber, Alain Taı̈eb, Julien Sénéschal, Michael J. Cork, C. Paul, Carsten Flohr, Stephan Weidinger, Magdalena Trzeciak, Thomas Werfel, Annice Heratizadeh, Ulf Darsow, Dagmar Simon, Antonio Torrelo, Pavel V. Chernyshov, J.‐F. Stalder, C. Gelmetti, Zsuzsanna Szalai, Åke Svensson, L.B. von Kobyletzki, L. De Raeve, Regina Fölster‐Holst, Stéphanie Christen‐Zaech, DirkJan Hijnen, Uwe Gieler, Jan Gutermuth, Christine Bangert, Phyllis I. Spuls, B Kunz, Johannes Ring, Andreas Wollenberg, Mette Deleuran

2021Journal of the European Academy of Dermatology and Venereology36 citationsDOI Open Access PDF

Abstract

European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics

Topics & Concepts

MedicineAtopic dermatitisCoronavirus disease 2019 (COVID-19)Task force2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DermatologyVaccinationImmunologyVirologyInternal medicineOutbreakDiseasePolitical scienceInfectious disease (medical specialty)Public administrationDermatology and Skin DiseasesAllergic Rhinitis and SensitizationFood Allergy and Anaphylaxis Research